Hematopoietic Stem Cell Transplantation (Hsct) Compared To Consolidation Chemotherapy (Ct) To Increase Leukemia Free Survival (Lfs) In Acute Myelogenous Leukemia (Aml) Patients Between 60 And 75 Years Irrespective Of Genetic Risk: Report From The Aml 2004 Of The East German Study Group (Osho).